Regional Account Associate Director At Novartis Gene Therapies
Current-Gene Replacement Therapy for Spinal Muscle Atrophy-KAM Advisory Council-#1 in Zolgensma Enrollments and Infusions in Nation for Launch Year 2019/2020-National Impact Award 2023 -#1 Launch to Date in Zolgensma Enrollments and Infusions in second commercial year.-2023 Impact Award